October 13, 2016
Theradiag: Revenue growth at end September 2016 +31%
THERADIAG a company specializing in in vitro diagnostics and theranostics, has reported its consolidated revenues for the 3rd quarter of 2016.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: nflammatory bowel diseases